跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68 条关于
“Lepu”
全部
68
临床试验
39
药物
15
机构
4
资讯
10
上个月
Lepu Biopharma and AstraZeneca Announce Positive Phase III Results for CMG901 in Advanced Gastric Cancer
10个月前
World's First EGFR-Targeted ADC Receives Approval in China for Nasopharyngeal Carcinoma
去年
ArriVent BioPharma Expands Portfolio with Novel ADC for GI Cancers, Reports Strong NSCLC Trial Results
11个月前
Roche Acquires Hansoh's CDH17-Targeting ADC HS-20110 in $1.45 Billion Deal
6个月前
Excalipoint Therapeutics Secures $68.7 Million in Seed Funding to Advance Next-Generation T-Cell Engager Pipeline
2个月前
Global TROP-2 Targeted Therapy Market Projected to Reach $3.29 Billion by 2031, Driven by ADC Innovation and Rising Cancer Prevalence
7个月前
Claudin18.2 ADC Race Intensifies as AstraZeneca Prepares Pivotal Data While Chinese Competitors Advance
3个月前
2026 China NRDL Negotiations: Record Submissions, Pre-Approval Access, and the Rise of ADCs, CAR-T, and Bispecific Antibodies
上个月
ArriVent Advances Firmonertinib Toward Pivotal EGFR Exon 20 NSCLC Data as ADC Pipeline Progresses
去年
Four Promising Gene and Cell Therapies Challenge Aldurazyme's Dominance in MPS I Treatment